| Name | Title | Contact Details |
|---|
At Blue Shield of California, we`re focused on fundamentally improving the ways in which members can access care and use their coverage. We`re investing in talented employees and new technologies to create an unrivaled member experience that elevates expectations and achieves our mission of making health care more accessible and affordable than ever. Today we are the third-largest health plan in the state and we`re dedicated to transforming the healthcare industry. Headquartered in San Francisco, with 18 additional offices across California, we`re proud to service over 4 million members and employ more than 6,000 people. We are an independent member of the Blue Shield Association. Blue Shield of California complies with applicable state laws and federal civil rights laws, and does not discriminate on the basis of race, color, national origin, ancestry, religion, sex, marital status, gender, gender identity, sexual orientation, age, or disability. Blue Shield of California cumple con las leyes estatales y las leyes federales de derechos civiles vigentes, y no discrimina por motivos de raza, color, país de origen, ascendencia, religión, sexo, estado civil, género, identidad de género, orientación sexual, edad ni discapacidad.
Basic Home Infusion is a highly specialized home infusion company providing high quality and cost effective at home services since 1983. BHI is JCAHO accredited and compliant with USP standards. As one of the largest independent specialty infusion providers in the United States, BHI offers dedicated nursing and infusion services in support of the patients BHI serves. By coordinating your patients care with BHI, whatever your needs, you can be assured of our commitment to quality.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Suncoast Center is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carolina Health Centers is a Greenwood, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.